Drug Trial Radar · NCT04934748
The GUARDIAN Trial - Vasopressor Sub-Study
Last checked: Nov 19, 2026Latest source record: Aug 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
6,254
Planned (sponsor's estimate)
Start
Jul 25, 2021
Primary completion
Dec 31, 2026
Study completion Apr 25, 2027
Sponsor
- Lead sponsor
- The University of Texas Health Science Center, HoustonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a sub-study of the overall GUARDIAN trial (NCT04884802) in which some GUARDIAN trial participants will be additionally randomized to norepinephrine or phenylephrine infusion to maintain the designated target intraoperative mean arterial pressure.
Conditions
- Blood Pressure
Interventions
Routine Blood Pressure ManagementProcedure
Routine blood pressure control.
Tight Blood Pressure ManagementProcedure
Tight blood pressure control.
PhenylephrineDrug
Phenylephrine will be infused at a rate sufficient to maintain the intraoperative MAP designated in the underlying GUARDIAN trial.
NorepinephrineDrug
Norepinephrine will be infused at a rate sufficient to maintain the intraoperative MAP designated in the underlying GUARDIAN trial.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with a Composite of Major Perfusion-Related ComplicationsTime frame: During the initial 30 days after major non-cardiac surgery
Locations
11 sites in 4 countries. Site status is shown where the registry gives one.
University of Nebraska Medical Center
Omaha, Nebraska
MetroHealth Medical Center
Cleveland, Ohio
Cleveland Clinic Fairview Hospital
Cleveland, Ohio
Cleveland Clinic Main Campus
Cleveland, Ohio
Beijing Shijitan Hospital, Capital Medical University
Beijing, China
Peking Union Medical College Hospital
Beijing, China
Shanghai Ninth People's Hospital
Shanghai, China
Shanghai Chest Hospital
Shanghai, China
West China Hospital
Sichuan, China
University of Thessaly
Larissa, Greece
National Defense College
Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.